Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
693,035 result(s) for "Post"
Sort by:
Post-traumatic stress disorder
\"Three distinguished experts share cutting-edge insights on Post-Traumatic Stress Disorder (PTSD), showing why it occurs, how it affects the development and existence of those it impacts, and how it can be treated\"-- Provided by publisher.
Counselling for post-traumatic stress disorder
This book addresses the specifics of counselling clients who have suffered major trauma, whether recently or in the past, and includes 18 detailed case examples together with transcripts of sessions. It is unique in covering the diagnosis and treatment of the full spectrum of post-traumatic states. This fully updated Third Edition includes the needs of special populations: children/adolescents, refugees and those in pain are also addressed. Additional material includes a new PTSD screening inventory and a counselling competence scale.
Psychological Symptoms and Rates of Performance Validity Improve Following Trauma-Focused Treatment in Veterans with PTSD and History of Mild-to-Moderate TBI
Iraq and Afghanistan Veterans with posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) history have high rates of performance validity test (PVT) failure. The study aimed to determine whether those with scores in the invalid versus valid range on PVTs show similar benefit from psychotherapy and if psychotherapy improves PVT performance. Veterans (N = 100) with PTSD, mild-to-moderate TBI history, and cognitive complaints underwent neuropsychological testing at baseline, post-treatment, and 3-month post-treatment. Veterans were randomly assigned to cognitive processing therapy (CPT) or a novel hybrid intervention integrating CPT with TBI psychoeducation and cognitive rehabilitation strategies from Cognitive Symptom Management and Rehabilitation Therapy (CogSMART). Performance below standard cutoffs on any PVT trial across three different PVT measures was considered invalid (PVT-Fail), whereas performance above cutoffs on all measures was considered valid (PVT-Pass). Although both PVT groups exhibited clinically significant improvement in PTSD symptoms, the PVT-Pass group demonstrated greater symptom reduction than the PVT-Fail group. Measures of post-concussive and depressive symptoms improved to a similar degree across groups. Treatment condition did not moderate these results. Rate of valid test performance increased from baseline to follow-up across conditions, with a stronger effect in the SMART-CPT compared to CPT condition. Both PVT groups experienced improved psychological symptoms following treatment. Veterans who failed PVTs at baseline demonstrated better test engagement following treatment, resulting in higher rates of valid PVTs at follow-up. Veterans with invalid PVTs should be enrolled in trauma-focused treatment and may benefit from neuropsychological assessment after, rather than before, treatment.
Journalists under fire : the psychological hazards of covering war
As journalists in Iraq and other hot spots around the world continue to face harrowing dangers and personal threats, neuropsychiatrist Anthony Feinstein offers a timely and important exploration into the psychological damage of those who, armed only with pen, tape recorder, or camera, bear witness to horror. Based on a series of recent studies investigating the emotional impact of war on the profession, Journalists under Fire breaks new ground in the study of trauma-related disorders. Feinstein opens with an overview of the life-threatening hazards war reporters face—abductions, mock executions, the deaths of close colleagues—and discusses their psychological consequences: post-traumatic stress disorder, depression, deterioration of personal relationships, and substance abuse. In recounting the experiences of reporters who encounter trauma on the job, Feinstein observes that few adequate support systems are in place for them. He tells the stories of media veterans who have seen it all, only to find themselves and their employers blindsided by psychological aftershocks. The book explores the biological and psychological factors that motivate journalists to take extraordinary risks. Feinstein looks into the psyches of freelancers who wade into war zones with little or no financial backing; he examines the different stresses encountered by women working in a historically male-dominated profession; and he probes the effects of the September 11 attacks on reporters who thought they had sworn off conflict reporting. His interviews with many of this generation's greatest reporters, photographers, and videographers often reveal extraordinary resilience in the face of adversity. Journalists under Fire is a look behind the public persona of war journalists at a time when the profession faces unprecedented risk. Plucking common threads from disparate stories, Feinstein weaves a narrative that is as fascinating to read as it is sobering to contemplate. What emerges are unique insights into lives lived dangerously.
The PTSD workbook : simple, effective techniques for overcoming traumatic stress symptoms
In the third edition of the best-selling The PTSD Workbook, psychologists and trauma experts Mary Beth Williams and Soili Poijula offer readers the most effective tools available for treating post-traumatic stress disorder (PTSD). In this fully revised and updated workbook, readers will learn how to move past the trauma they have experienced; manage symptoms such as insomnia, anxiety, and flashbacks; and find important updates reflecting the new DSM-V definition of PTSD.
Transforming the Living Legacy of Trauma
Traumatic experiences leave a \"living legacy\" of effects that often persist for years and decades after the events are over.Historically, it has always been assumed that re-telling the story of what happened would resolve these effects.
Treating the trauma survivor : an essential guide to trauma-informed care
\"Treating the Trauma Survivor is a practical guide to assist mental health, health care, and social service providers in providing trauma-informed care. This resource provides essential information in order to understand the impacts of trauma by summarizing key literature in an easily accessible and user-friendly format. Providers will be able to identify common pitfalls and avoid re- traumatizing survivors during interactions. Based on the authors extensive experience and interactions with trauma survivors, the book provides a trauma-informed framework and offers practical tools to enhance collaboration with survivors and promote a safer helping environment. Mental health providers in health care, community, and addictions settings as well as health care providers and community workers will find the framework and the practical suggestions in this book informative and useful\"- Provided by publisher.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD, including those with common comorbidities such as dissociation, depression, a history of alcohol and substance use disorders, and childhood trauma. After psychiatric medication washout, participants ( n  = 90) were randomized 1:1 to receive manualized therapy with MDMA or with placebo, combined with three preparatory and nine integrative therapy sessions. PTSD symptoms, measured with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5, the primary endpoint), and functional impairment, measured with the Sheehan Disability Scale (SDS, the secondary endpoint) were assessed at baseline and at 2 months after the last experimental session. Adverse events and suicidality were tracked throughout the study. MDMA was found to induce significant and robust attenuation in CAPS-5 score compared with placebo ( P  < 0.0001, d  = 0.91) and to significantly decrease the SDS total score ( P  = 0.0116, d  = 0.43). The mean change in CAPS-5 scores in participants completing treatment was −24.4 (s.d. 11.6) in the MDMA group and −13.9 (s.d. 11.5) in the placebo group. MDMA did not induce adverse events of abuse potential, suicidality or QT prolongation. These data indicate that, compared with manualized therapy with inactive placebo, MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated, even in those with comorbidities. We conclude that MDMA-assisted therapy represents a potential breakthrough treatment that merits expedited clinical evaluation. Results from a phase 3, double-blind, randomized, placebo-controlled trial demonstrate that MDMA-assisted therapy is safe and effective in treating severe post-traumatic stress disorder.